Also reported as dba as TLC, The Liver Company is broadly defined as a biotechnology company but appears to have no obvious online footprint. It appears likely that the listed SBIR funded NIH project is actually underway at a firm now dba as ORSOBIO, Inc. ..... OrsoBio, Inc. is undicated as a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. Currently fhe ifrm is reported as having four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.
